CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 980 enrolled
Drug / intervention
Transtelephonic monitoring (TTM) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00294645
NCT00294645N/ACompleted

Pacemaker Remote Follow-up Evaluation and Review

Medtronic Cardiac Rhythm and Heart Failure·interventional·Posted Feb 22, 2006·Updated Oct 19, 2010

In Brief

A clinical study evaluating Transtelephonic monitoring (TTM) and Medtronic CareLink® Network for Bradycardia and Arrhythmia. Completed, enrolled 980 participants across 45 sites.

Detailed Summary

The purpose of the study is to compare remote pacemaker follow-up to current standard of care follow-up. The study will compare the rate of first diagnosis of clinically actionable events between patients who utilize the Medtronic Carelink® Network (Remote arm) versus patients who are followed via routine office visits augmented by transtelephonic monitoring (TTM)(Control arm).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMedtronic

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 22, 2006
Enrollment StartApr 1, 2004
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 20.4 years ago

Interventions

Transtelephonic monitoring (TTM)other

TTM conducted at 2 month intervals. For patients with dual-chamber pacemakers, an in-office visit was required at 6 months (rather than TTM transmission for patients with single-chamber pacemakers). Follow-up frequency established to mimic best case standard of care when utilizing TTM for follow-up. A 12-month in-office visit completed the follow-up period.

Medtronic CareLink® Networkother

Remote pacemaker interrogation conducted at 3 month intervals. Follow-up frequency established to mimic best case standard of care when utilizing implantable cardioverter defibrillator (ICD) remote interrogation for follow-up. A 12-month in-office visit completed the follow-up period.